Zydus Lifesciences Ltd.

BSE: 532321 | NSE: ZYDUSLIFE

Mid Cap | Pharmaceuticals & Drugs

891.55

17.90 (2.05%)

< Home < Back

Zydus Lifesciences Ltd. News

>>

Zydus Lifesciences gets final approval from USFDA for Colestipol Hydrochloride tablets

>>

Zydus Lifesciences informs about press release

>>

USFDA inspects Zydus Lifesciences’ injectable facility in Gujarat

>>

Zydus Lifesciences soars on getting approval from USFDA for Nitroglycerin Sublingual tablets

>>

Zydus Lifesciences informs about press release

>>

Zydus Lifesciences gets approval from USFDA for Nitroglycerin Sublingual tablets

>>

Zydus Lifesciences jumps as its arm executes asset purchase agreement with BridgeBio

>>

Zydus Lifesciences’ arm executes asset purchase agreement with BridgeBio

>>

Zydus Lifesciences gets DCGI’s approval for Oxemia

>>

Zydus Lifesciences informs about press release

<< < 67 68 69 ...168 > >>